EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,950
-580 (-3.73%)
At close: Feb 27, 2026

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Pharmaceuticals
96.04B69.37B55.47B39.38B28.49B
Pharmaceuticals Growth
38.45%25.06%40.83%38.24%-
Total
96.04B69.37B55.47B39.38B28.49B
Total Growth
38.45%25.06%40.83%38.24%-

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
South Korea
2.51B4.47B4.42B4.15B
South Korea Growth
-43.93%1.13%6.41%-
Overseas
66.86B51.00B34.96B24.34B
Overseas Growth
31.11%45.85%43.68%-
Total
69.37B55.47B39.38B28.49B
Total Growth
25.06%40.83%38.24%-
Source: S&P Global Market Intelligence.